1National Health (Pharmaceutical Benefits - Early Supply) Amendment Instrument 2015 (No. 9) - specification under subsection 84AAA(2) (PB 103 of 2015)

---

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 20.2 title: Normal.dot

?xml version="1.0" encoding="utf-8" standalone="no"?>

Image unavailable in extracted text

 

PB 103 of 2015

National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 9) – specification under subsection 84AAA(2)

 

National Health Act 1953

 

I, PAUL CREECH, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated     23 October  2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PAUL CREECH

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

 

 

 

---

 

Amendment determination – Pharmaceutical Benefits – Early Supply

 

 

1 Name of Instrument

 

(1)           This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 9) – specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as PB 103 of 2015.

 

2 Commencement

 

This Instrument commences on 1 November 2015.

 

3 Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).

 

 

Schedule 1 Amendments

 

[1]                Schedule 1, after entry for Pindolol in the form Tablet 15 mg

insert:

• Ponatinib Tablet 15 mg (as hydrochloride) Oral 60 5 60
• Tablet 45 mg (as hydrochloride) Oral 30 5 30